Rigel Pharma (RIGL) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $32.91 -1.38%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $28.1 million versus the consensus estimate of $27.2 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- SpaceX receives Baa1 rating from Moody's with stable outlook
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
